Monday, March 17, 2025
3:00PM – 4:00PM ET
Please note this TeleECHO program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.
PRESENTING FACULTY & PROGRAM CHAIR
 |
Hanny Al-Samkari, MD Classical Hematologist and Clinical Investigator The Peggy S. Blitz Endowed Chair in Hematology/Oncology Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Boston, MA |
PROGRAM OVERVIEW
This interactive and engaging educational activity is designed to support hematologists in advancing their knowledge and clinical skills related to the diagnosis and management of thalassemias. The program provides exploration of the genetic and clinical characteristics associated with α- and β-thalassemias, as well as a review of diagnostic standards and management of transfusion-related complications. Participants will examine clinical evidence supporting emerging therapeutic strategies, including pyruvate kinase activation, as well as practical approaches to incorporating novel pharmacologic therapies into treatment.
TARGET AUDIENCE
This activity is designed to meet the educational needs of hematologists involved in the diagnosis and management of patients with thalassemias.
LEARNING OBJECTIVE
Upon the completion of this program, attendees should be able to:
- Assess the genetic and clinical characteristics of thalassemias as well as the diagnostic standards and transfusion-related complications in managing thalassemias
- Examine clinical evidence supporting the use of pyruvate kinase activation in treating thalassemia
- Develop treatment strategies that incorporate new pharmacological treatments for managing patients with thalassemia
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture the faculty may mention the use of medications for both US Food and Drug Administration (FDA)-approved and non-FDA-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
